| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.
|
Science
|
1999
|
18.55
|
|
2
|
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay.
|
J Clin Microbiol
|
2000
|
13.34
|
|
3
|
Nipah virus: a recently emergent deadly paramyxovirus.
|
Science
|
2000
|
9.39
|
|
4
|
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.
|
J Clin Microbiol
|
2000
|
8.80
|
|
5
|
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay.
|
J Clin Microbiol
|
2000
|
4.61
|
|
6
|
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.
|
J Virol
|
2001
|
4.27
|
|
7
|
West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
|
J Virol
|
2001
|
3.65
|
|
8
|
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
|
Virology
|
1997
|
3.48
|
|
9
|
West Nile virus: a reemerging global pathogen.
|
Emerg Infect Dis
|
2001
|
3.27
|
|
10
|
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.
|
Virology
|
1983
|
3.24
|
|
11
|
New mouse model for dengue virus vaccine testing.
|
J Virol
|
1999
|
3.18
|
|
12
|
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
|
J Virol
|
1993
|
2.69
|
|
13
|
Widespread West Nile virus activity, eastern United States, 2000.
|
Emerg Infect Dis
|
2001
|
2.52
|
|
14
|
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein.
|
Virology
|
1992
|
2.48
|
|
15
|
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America.
|
Clin Infect Dis
|
1999
|
1.93
|
|
16
|
West Nile virus in the United States: guidelines for detection, prevention, and control.
|
Viral Immunol
|
2000
|
1.85
|
|
17
|
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies.
|
Virology
|
1982
|
1.80
|
|
18
|
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes.
|
Virology
|
1985
|
1.62
|
|
19
|
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies.
|
J Immunol
|
1982
|
1.60
|
|
20
|
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies.
|
J Immunol
|
1984
|
1.58
|
|
21
|
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.
|
Virology
|
1993
|
1.56
|
|
22
|
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.
|
Am J Trop Med Hyg
|
1997
|
1.45
|
|
23
|
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999.
|
Emerg Infect Dis
|
2000
|
1.43
|
|
24
|
Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.
|
J Virol
|
1998
|
1.36
|
|
25
|
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
|
Virology
|
1994
|
1.33
|
|
26
|
Monoclonal antibodies against the flavivirus West Nile.
|
J Gen Virol
|
1982
|
1.33
|
|
27
|
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region.
|
Am J Trop Med Hyg
|
1998
|
1.30
|
|
28
|
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay.
|
J Clin Microbiol
|
1987
|
1.29
|
|
29
|
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus.
|
Virology
|
1980
|
1.28
|
|
30
|
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
|
Virology
|
1990
|
1.25
|
|
31
|
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies.
|
J Gen Virol
|
1982
|
1.24
|
|
32
|
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature.
|
Arch Virol
|
2002
|
1.22
|
|
33
|
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.
|
J Infect Dis
|
1994
|
1.18
|
|
34
|
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies.
|
J Virol
|
1985
|
1.18
|
|
35
|
Identification of Highlands J virus from a Florida horse.
|
Am J Trop Med Hyg
|
1988
|
1.16
|
|
36
|
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus.
|
Virology
|
1985
|
1.12
|
|
37
|
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
|
J Virol
|
1988
|
1.10
|
|
38
|
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes.
|
J Gen Virol
|
1991
|
1.10
|
|
39
|
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus.
|
J Gen Virol
|
1982
|
1.09
|
|
40
|
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes.
|
J Clin Microbiol
|
1988
|
1.08
|
|
41
|
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication.
|
Virology
|
1991
|
1.05
|
|
42
|
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus.
|
Am J Trop Med Hyg
|
1988
|
1.04
|
|
43
|
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice.
|
Virology
|
1995
|
1.02
|
|
44
|
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years.
|
Emerg Infect Dis
|
1997
|
1.02
|
|
45
|
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein.
|
J Gen Virol
|
1988
|
1.01
|
|
46
|
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia.
|
Am J Trop Med Hyg
|
1988
|
1.00
|
|
47
|
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus.
|
J Gen Virol
|
1993
|
1.00
|
|
48
|
Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand.
|
Vaccine
|
2005
|
0.98
|
|
49
|
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide.
|
Virology
|
1990
|
0.97
|
|
50
|
West Nile virus.
|
JAMA
|
2001
|
0.94
|
|
51
|
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
|
J Gen Virol
|
1988
|
0.93
|
|
52
|
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex.
|
Am J Trop Med Hyg
|
1998
|
0.92
|
|
53
|
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human.
|
J Clin Microbiol
|
1990
|
0.91
|
|
54
|
T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.
|
J Virol
|
1991
|
0.88
|
|
55
|
Localization of a protective epitope on a Venezuelan equine encephalomyelitis (VEE) virus peptide that protects mice from both epizootic and enzootic VEE virus challenge and is immunogenic in horses.
|
Vaccine
|
1995
|
0.87
|
|
56
|
Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
|
J Gen Virol
|
1990
|
0.86
|
|
57
|
Specificity of the murine T helper cell immune response to various alphaviruses.
|
J Gen Virol
|
1989
|
0.85
|
|
58
|
Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies.
|
J Med Virol
|
1990
|
0.81
|
|
59
|
Detection of eastern equine encephalitis virus in infected mosquitoes using a monoclonal antibody-based antigen-capture enzyme-linked immunosorbent assay.
|
Am J Trop Med Hyg
|
2001
|
0.81
|
|
60
|
Effects of 17beta-estradiol on the replication of rubella virus in an estrogen-responsive, continuous cell line.
|
J Virol
|
1979
|
0.80
|
|
61
|
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. III. Identification of a protective peptide derived from the carboxy-terminal extramembranal one-third of the protein.
|
Virology
|
1991
|
0.80
|
|
62
|
Characteristics of a persistent rubella infection in a human cell line.
|
J Gen Virol
|
1981
|
0.80
|
|
63
|
Differentiation of parapoxviruses by application of orf virus-specific monoclonal antibodies against cell surface proteins.
|
Vet Immunol Immunopathol
|
1991
|
0.78
|
|
64
|
Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice.
|
J Neurovirol
|
2009
|
0.76
|
|
65
|
A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.
|
J Virol
|
1992
|
0.75
|
|
66
|
Laboratory testing for West Nile virus: panel discussion.
|
Ann N Y Acad Sci
|
2001
|
0.75
|
|
67
|
Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus.
|
Vaccine
|
1994
|
0.75
|
|
68
|
Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus.
|
Hybridoma
|
1999
|
0.75
|